Genome-wide CHIPseq has revealed that AR in prostate CAFs has distinct binding sites and binding sequence motifs compared with tumor cells, suggesting differences in AR-regulated genes between the two cell populations [24]. The gene discussed is AR; the disease is neoplasm.